Meihua International Medical Technologies Company Ltd (PK) (MHUAF)

MHUA changed to MHUAF. Delisted from the Nasdaq to the OTC

https://otce.finra.org/otce/dailyList?viewType=Additions

Buys348k/sells 9k,no T trades,death hour is over,watch demand for explosion

Insane buying ratio https://ih.advfn.com/stock-market/NASDAQ/meihua-international-med-MHUA/trades

5.73 book,undervalued big time,shares to short dropping

charting up,sales 94m,profit 9.28m,insider 61%

Pump and dump

Will it grow legs after 9:30

Oh boy

Meihua International Medical Technologies Facilitates World's Second* 5G Remote Robot-Assisted Lobectomy
YANGZHOU, China, July 31, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today announced that its NT-2000 surgical path analysis system successfully supported the world's second* 5G remote robot-assisted lobectomy. This procedure, we believe the first of its kind in China's Yangzi Delta area, was performed on July 15, 2024, at Yangzhou University Affiliated Hospital by a team from Shanghai Chest Hospital.

"We are honored that our cutting-edge technology could assist the advanced 3D imaging for surgical mapping in this sophisticated procedure," said Mr. Yongjun Liu, Chairman of Meihua, "Despite a physical distance of over 200 kilometers between the surgical team and the patient, the operation was executed seamlessly in just one hour, thanks to 5G technology and the precision of the robotic surgical system. We believe that robot-assisted surgery has made significant strides due to its clinical effectiveness, low risk, and quick recovery times. We also believe that successful implementations improve the quality of medical services, allowing patients to access diverse, personalized, and high-quality healthcare locally. We anticipate that this innovation will not only ease the workload on medical staff but also address disparities in medical resource distribution across China. Moving forward, Meihua will continue in its efforts to innovate and enhance healthcare outcomes for patients."

The development of Meihua's robotic surgical systems is part of the Company's strategic initiatives to increase sales of high-end products and broaden its customer base. The Company has introduced new overseas technologies, including minimally invasive surgical robot systems, and established a dedicated research and development team focused on robotic-assisted surgery (RAS) systems. The Company believes its NT-2000 system's real-time monitoring and guidance capabilities enable precise targeting of surgical sites, improving the accuracy and success rates of operations. The RAS project is being developed in conjunction with the Hope City Medical Park in Hainan province, China. The project is expected to be completed in the fall of 2025.

* We believe this is the World's second 5G remote robot-assisted lobectomy, as reported by Yangzhou University Affiliated Hospital: https://mp.weixin.qq.com/s/HuApwLs3V8rRib1nSpUMXQ and Yangzhou Daily: http://news.yznews.com.cn/2024-07/27/content_7674119.htm.

MHUA..................................................https://stockcharts.com/h-sc/ui?s=MHUA&p=W&b=5&g=0&id=p86431144783

Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million

Sounds about right...plus their earnings are all unaudited.

MHUA new 52 week low

MHUA new 52 week low

Indeed it is... if we are to survive, you can only buy absolutely bottoms based on charting and other signs which it seems you obviously rely on... and company's with low share structures, slim history of reverse Splits and Dilution and instead earning millions in revenue... Then you can expect that your profit will be safe(r)... otherwise every ticker is set to fail in the months ahead.... boyyy we thought 2021 to now was it.... we couldn't have been more wrong lol....

well said bro,yea trading has changed more in last 2 years than in all the 30 i have traded,darkpool mm blackrock crooks with ai algos can steal about 90% of moves between bid and ask,(10% used to be acceptable) it has forced trading to evolve to selling even the most promising ticker if its not running up 150% every 5min(slight exaggeration) or if it pulls back 30% from 150%(its still up 120%,but to many ppl bought around same pps because of mms theft) ,causing more of what ppl call pump and dumps,implying/thinking its the ticker co. fault,(very few are), i dont blame traders,protecting profit/preventing loss is essential to survival, our forced new way to trade is moving more wealth from middle class to big banks(the mms) than ever before

Not just China and otc... these days it's pretty much everything of the market as all the share prices were inflated during Quantitative Easing

China and OTC just doesn't have the same following or respect, but their economy is growing... China has cheaper interest rates too... OTC operates like a casino though even while the markets have crashed, the otc can run for days randomly when you least expect lol

yep,trading any ticker (even reputable ones) above the volatility rating is extremely risky,all china and otc are scam garbage,like lotto or pulling the handle on a slot machine, expect to lose it all!!!

$MHUA because finding Chinese scams after is bagholder city.

currently on my scanner #1 TANH ,#2 AGBA,#3 CPHI,#4 GDHG (all china setting)

any offering has dilutive effect,look in details of exercise price(if any,if none they can sell at any price) if ex.price is .50 and current pps is .10 ,400% upside until dilution,if ex. pps is .10 and current pps is .50 its dilutable down to .10

What I don't understand is this... is this a dilutive offering?

Meihua International Medical Technologies Co., Ltd. Announces Closing of Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering

Source: PR Newswire (US)

YANGZHOU, China, Jan. 2, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today announced the closing of its previously disclosed registered direct offering with certain accredited institutional investors to purchase an initial $6 million tranche in the offering of up to $50.5 million of its 7% Original Issue Discount Senior Convertible Promissory Notes (the "Initial Notes"), and five-year ordinary share purchase warrants to purchase 1,205,255 ordinary shares of the Company (the "Initial Warrants"), exercisable at $2.9869 per ordinary share, in a concurrent private placement, for gross proceeds of approximately $5,580,000.

This one here could still break out... low floater, easy runner

many chinas poping,finding them before they pop is best,dd CPHI,had a 13g filing,merger in works,real product,could be a nice winner from .10

400% up to 10% down

Lol now LET than yesterday

Scan again $4 premarket lol

Low floater, good revenue, essential product supplier in the medical field... check back a year ago when it pumped to 45.50.... I think 5-10 is possible after 8 or 930.... Will keep an eye...

Pumping back up

She is running hard on heavy pre-market volumes!

MUHA new 52 week low

Biggest bid I have seen today, 28k,7mms deep, $1.74 ,I am excited now that demand is growing,no dumping yet,we shall see

MHUA #2 on my scanner so I had to start loading,Rhdl is #1,scalped and done for me

Volume start oct.13th,accumulation.000,today it’s 1.68,steady loading 32 days now,insiders?institutions? Retail? Lol

Buying vol up .50%(that might be me)

NOT OPTIONABLE,short interest only 3,425 shares

Institutional buying up 409%,insiders own 67%,great sign with that much skin in the game

8M float,24M o/s,profit 6.75M,no debt,sales 97M,647 employees,book pps $5.80,volatility 10%